| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-79 |
Sentence |
denotes |
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment |
| T2 |
81-89 |
Sentence |
denotes |
Abstract |
| T3 |
90-397 |
Sentence |
denotes |
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. |
| T4 |
398-607 |
Sentence |
denotes |
The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. |
| T5 |
608-827 |
Sentence |
denotes |
Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. |
